Flumazenil Injection, Solution
Product Images NDC 51662-1254

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Flumazenil (NDC 51662-1254). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co. Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5 mL Vial Label (1000570 0143 9784 01 Flumazenil 5 mL)

FLUMAZENIL Injection, USP label for a 5 mL multiple dose vial with a strength of 0.1 mg/mL (0.5 mg/5 mL). The label includes storage and dosage instructions, manufacturer HKMA Farmacêutica (Portugal), and the distributor WEST-WARD, Easton, NJ. It is marked sterile, for intravenous use only, and prescription only.*

FDA Label Image

Serialized Label (51662 1254 1 Flumazenil 5 Serialized)

FLUMAZENIL injection, solution in a small clear glass vial with an orange cap. The label shows the product name FLUMAZENIL and strength of 0.5 mg/5 mL (0.1 mg/mL) with additional text including a lot number and distributor information by HF Acquisition Co., LLC. The vial is intended for intravenous use and is marked Rx only.*

FDA Label Image

Boxed Warning (Boxed Warning)

A text panel warning about FLUMAZENIL use, stating an association with seizures. It notes seizures occur most frequently in patients on long-term benzodiazepines or with serious cyclic antidepressant overdose. It advises practitioners to individualize dosage and be prepared to manage seizures.*

FDA Label Image

Tabel (Clinica Pharma Tabel)

A data table presenting pharmacokinetic parameters including Cmax (ng/mL), AUC (ng·hr/mL), Vss (L/kg), Cl (L/hr/kg), and half-life (minutes) with their associated values, percentages, and ranges.*

FDA Label Image

Chart (Clinical Pharma Chart)

A line chart illustrating the magnitude and duration of reversal of sedation as a function of Flumazenil doses (0.2, 0.6, and 1 mg) measured by blood levels in ng/mL. The graph shows alertness levels over 100 minutes after Flumazenil injection, indicating stages from baseline sedation to completely alert at different dosage levels.*

FDA Label Image

Structure (Structure)

Chemical structure of Flumazenil, showing its molecular framework including fused rings with fluorine and ethyl ester functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.